CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a technology called OssiGel to create human mini-bones in mice for studying bone-related cancers. By using patient-derived cells mixed with OssiGel, the project aims to improve the reliability of cancer research and personalized drug testing.
Cancer is a huge societal concern representing one death out of sixth in 2020.
The vast majority of existing cancers emerge or ultimately develop in bones: leukemia, lung, breast, prostate, kidney, bladder.
Our bones are thus considered a privileged harbor for cancer cells, and this is also associated with a very poor survival prognostic: bone-developing cancers account for ~3 million deaths each year.
When at all existing, treatments are poorly effective: 92% of new therapies successful in prec…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
